Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: The Modena Study Group proposal

Breast Cancer Research and Treatment

Volumn 55, Issue 3, 1999, Pages 213-221

  Federico, Massimo ^a,b   Maiorana, A ^a   Mangone, L ^a   Turchetti, D ^a   Canossi, B ^a   Cortesi, L ^a   Romagnoli, R ^a   Silingardi, V ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Breast cancer screening; Clinical and mammographic surveillance; Familial breast cancer; Genetic cancer susceptibility; Hereditary breast ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL EXAMINATION; CLINICAL TRIAL; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; OVARY CANCER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROBABILITY;

ADULT; AGED; BREAST NEOPLASMS; CLUSTER ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; PEDIGREE; RISK FACTORS;

EID: 0032834654     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006192230332     Document Type: Article

References (33)

1. Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J: The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179: 29-32, 1994
2. Lynch HT, Lynch J, Conway T, Watson P, Feunteun J, Lenoir G, Narod 5, Fitgibbons R, Jr.: Hereditary breast cancer and family cancer syndromes. World J Surg 18: 21-31, 1994
3. Newman B, Austin MA, Lee M, King MC: Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA 85: 3044-3048, 1988
4. Li FP, Garber JE, Friend FH, Strong LC, Patenaude AF, Juengst ET, Reilly PR, Correa P, Fraumeni JF, Jr.: Recommendations of predictive testing for germ-line p53 mutations among cancer-prone individuals. J Natl Cancer Inst 84: 1156-1160, 1992
5. Birch JM: The Li Fraumeni cancer family syndrome. J Pathol 161: 1-2, 1990
6. Morrell D, Cromartie E, Swift M: Mortality and cancer incidence in 263 patients with AT. JNCI 77: 89-92, 1986
7. Lynch HT, Guirgis HA, Albert 5, Brennan M, Lynch J, Kraft C, Pocekay D, Vaughns C, Kaplan A: Familial association of carcinoma of the breast and ovary. Surg Gynecol Obstet 138: 717-724, 1974
8. Lynch HT, Krush AJ, Guirgis H: Genetic factors in families with combined gastrointestinal and breast cancer. Am J Gastroenterol 59: 31-40, 1973
9. Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC: Lhermitte-Duclos disease and Cowden disease: A single phakomatosis. Ann Neurol 29: 517-523, 1991
10. Lynch HT, Watson P, Conway TA, Lynch JF: Natural history and age at onset of hereditary breast cancer. Cancer 69: 1404-1407, 1992
11. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990
12. Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BA, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast susceptibility gene, BRCA2, to chromosome 13q 12-13. Science 265: 2088, 1994
13. Malkin D, Li FP, Strong LC, Fraumeni JF, Jr., Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233-1238, 1990
14. Savitsky K, Sfez 5, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G: The complete sequence of the coding region of ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4: 2025-2032, 1995
15. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero, Bonney G, Gold K, Trock B, Main D, Lynch J, Fulmore C, Snyder C, Lemon S, Conway T, Tonin P, Lenoir G, Lynch H: BRCAI testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. JAMA 275: 1885-1892, 1996
16. Lynch HT, Watson P, Conway T, Fitzimmons ML, Lynch J: Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 11: 263-267, 1988
17. Burke W, Daly M, Garber J, Botkin J, Kahn MJE, Lynch P, McTieman A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C, for the Cancer Genetics Studies Consortium: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA 277: 997-1008, 1997
18. Lynch HT, Watson P, Conway TA, Lynch JF: Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat 15: 63-71, 1990
19. Vasen HFA, Mecklin JP, Watson P, Utsunomiya J, Bertario L, Lynch P, Svendsen LB, Cristofaro G, Muller H, Khan PM: Surveillance in HNPCC: An international cooperative study of 165 families. Dis Colon Rectum 36: 1-4, 1993
20. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Hakansson S, Andersen TI, Borg A, Borresen Dale AL, Lindblom A: A screening for BKCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 57: 2474-2477, 1997
21. Vasen HFA, Mecklin JP, Khan PM, Lynch TH: The International Collaborative Study Group on Hereditary Non-polyposis Colorectal Cancer. Dis Colon Rectum 34: 424-425, 1991
22. Claus EB: The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Cancer 73: 643, 1993
23. Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, Layde PM: Family history and risk of breast cancer. JAMA 253: 1908-1913, 1985
24. Walker RA, Lees E, Webb MB, Dearing SJ: Breast carcinomas occurring in young women (35 years) are different. Br J Cancer 74: 1796-1800, 1996
25. Otten JD, van Dick JA, Peer PG, Straatman H, Verbeek AL, Mravunac M, Hendrikis JH, Holland R: Long term breast cancer screening in Nijmegen, The Netherlands: The nine rounds from 1975-92. J Epidemiol Commun Health 50: 353-358, 1996
26. Evans WP III, Starr AL, Bennos S: Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology 204: 489-491, 1997
27. John V, Ewen K, Kurz E, Teske HJ: Value of different systems of mammography records with regard to their exposure to radiation and their information content. Strahlentherapie 154: 101-106, 1978
28. Mettler FA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RD, Linver MN: Benefits versus risks from mammography: A critical reassessment. Cancer 77: 903-909, 1996
29. Vasen HFA, Offerhaus GJA, den Hartog Jager FC, Menko FH, Nagengast FM, Griffioen G, van Hogezand RB, Heintz AP: The tumour spectrum in hereditary non-polyposis colorectal cancer: A study of 24 kindreds in The Netherlands. Int J Cancer 46: 31-34, 1990
30. Filippini L, Braga M, Perna E, Bianchi AM, Bettoni C, Lucini L, Pezzola D, Pinelli D, Tonini G, Callca F: Results of a mammographic and clinical screening in a health district (USSL) of Brescia, Italy. Tumori 82: 430-436, 1996
31. Paci E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli del Turco M: Early indicators of efficacy of breast cancer screening programmes: Results of the Florence District Programme. Int J Cancer 46: 198-202, 1990
32. Elston CW: The assessment of histological differentiation in breast cancer. Aust N Z J Surg 54: 11-15, 1984
33. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991